Neuromodulation Market

Neuromodulation Market by Technology- Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation), Application (Ischemia, Chronic Pain, Parkinson’s, Depression, Tremor, Epilepsy, Migraine) - Global Forecast to 2025

Report Code: BT 3571 Feb, 2020, by marketsandmarkets.com

[156 Pages Report] The global neuromodulation market is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR of 8.6% between 2020 and 2025. The growth of this market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders. However, the high cost of neuromodulation procedures and equipment, along with the dearth of a trained workforce, is expected to restrain the growth of this market during the forecast period.

Neurostimulation Market

In 2019, Parkinson’s disease held the largest share of the deep brain stimulation market, by application

Based on application, the deep brain stimulation market is segmented into Parkinson’s disease, tremor, depression, and other DBS applications. Parkinson’s disease accounted for the largest share of this market in 2019. The growth of this segment is attributed to the rising incidence of the disease and growing R&D activity in this area.

Neurostimulation Market

The Asia Pacific neuromodulation market is expected to grow at the highest CAGR during the forecast period

The Asia Pacific is expected to grow at the highest rate in the market. The major factors driving the growth of this market include the high incidence of neurological disorders, increasing public and private investments, and ongoing research.

Key Market Players

The prominent players in the neuromodulation market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel). Major players have focused on product launches, agreements, and partnerships to increase their shares in the global market.

Medtronic is one of the leading players in the market. The company’s leading position can be attributed to its wide portfolio of neuromodulation devices and strong geographical footprint. The company operates in the US, Europe, and the Asia Pacific. It serves clinicians, physicians, hospitals, and patients in more than 160 countries. R&D is a key area of focus for Medtronic—it invested USD 2,330 million in 2019, as compared to USD 2,256 million in 2018 and USD 2,193 million in 2017. The company also focuses on organic as well as inorganic growth strategies to gain a competitive edge.

Scope of the report

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Technology, Application, and Region

Geographies covered

North America, Europe, Asia Pacific, and Rest of the World

Companies covered

Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova (UK), Synapse Biomedical (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), BioControl Medical (Israel), Bioness (US), Soterix Medical (US), Integer Holdings Corporation (US), Bioinduction (UK), GiMer Medical (Taiwan), GTX Medical (Netherlands), Helius Medical Technologies (US), MicroTransponder (US), Neuronano (US), and BlueWind (Israel).

The research report categorizes the neuromodulation market into the following segments and subsegments:

By Technology

  • Internal Neuromodulation
    • Spinal Cord Stimulation
    • Deep Brain Stimulation
    • Vagus Nerve Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
  • External Neuromodulation
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Transcranial Magnetic Stimulation (TMS)
    • Respiratory Electrical Stimulation (RES)

By Application

  • Spinal Cord Stimulation Market, By Application
    • Failed Back Syndrome
    • Chronic Pain
    • Ischemia
  • Deep Brain Stimulation Market, By Application
    • Parkinson’s Disease
    • Tremor
    • Depression
    • Other DBS Applications
  • Sacral Nerve Stimulation Market, By Application
    • Urine Incontinence
    • Fecal Incontinence
  • Vagus Nerve Stimulation Market, By Application
    • Epilepsy
    • Other VNS Applications
  • Gastric Electrical Stimulation Market, By Application
    • Gastroparesis
    • Obesity
  • Transcutaneous Electrical Nerve Stimulation Market, By Application
    • Treatment-resistant Depression
    • Other TENS Applications
  • Transcranial Magnetic Stimulation Market, By Application
    • Depression
    • Migraine Headache
  • Respiratory Electrical Stimulation Market, By Application
    • Spinal Cord Injury

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East and Africa

Recent Developments

  • In 2019, NeuroSigma signed a partnership agreement with Teijin Limited (Teijin) (Japan). The partnership granted Teijin Pharma, the core company of Teijin’s healthcare business, exclusive rights to market NeuroSigma’s Monarch eTNS system in Japan, as well as the company’s TNS patent rights in Japan related to the non-invasive treatment of ADHD.
  • In 2018, Abbott signed an agreement with the National Institutes of Health (NIH) (US). As per the agreement, Abbott will provide neuromodulation technologies, including directional DBS, SCS, and DRG therapy, for NIH research to explore their applications in chronic pain and progressive movement disorders.
  • In 2017, Medtronic signed a partnership agreement with Mercy (US) to establish a new data sharing and analysis network that helps gather clinical evidence for medical device innovation and patient access

Critical questions answered in the report:

  • Which regions are likely to grow at the highest CAGR?
  • What are the recent trends affecting the neuromodulation market?
  • Who are the key players in the market, and how intense is the competition?
  • What are the application areas of neuromodulation devices?
  • What are the challenges hindering the adoption of neuromodulation devices?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Research Data
    2.2 Secondary Data
           2.2.1 Secondary Sources
    2.3 Primary Data
           2.3.1 Key Data From Primary Sources
    2.4 Market Size Estimation
           2.4.1 Bottom-Up Approach
           2.4.2 Top-Down Approach
           2.4.3 Growth Forecast
    2.5 Market Breakdown and Data Triangulation
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 34)
    4.1 Neuromodulation: Market Overview
    4.2 North America: Neuromodulation Market, By Technology (2019)
    4.3 Global Spinal Cord Stimulation Market, By Application

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Prevalence of Neurological Disorders
                    5.2.1.2 Research Into Expanding the Applications of Neuromodulation
                    5.2.1.3 Rising Awareness on Neurodegenerative Disorders
           5.2.2 Restraints
                    5.2.2.1 High Cost of Neuromodulation Procedures
           5.2.3 Opportunities
                    5.2.3.1 Expansion in Emerging Economies
           5.2.4 Challenges
                    5.2.4.1 Dearth of Trained Professionals

6 Neuromodulation Market, By Technology (Page No. - 41)
    6.1 Introduction
    6.2 Internal Neuromodulation
           6.2.1 Spinal Cord Stimulation
                    6.2.1.1 Rising Incidence of Indications and Efficacy & Reversibility of Procedure Have Supported the Adoption of Scs
           6.2.2 Deep Brain Stimulation
                    6.2.2.1 Increasing Research has Driven the Development of Advanced Dbs Systems
           6.2.3 Vagus Nerve Stimulation
                    6.2.3.1 Rising Disorder Incidence and Growing Geriatric Population are Driving Market Growth
           6.2.4 Sacral Nerve Stimulation
                    6.2.4.1 Effectiveness of Sns and Rising Incidence of Urological Disorders are the Key Growth Drivers for This Market
           6.2.5 Gastric Electrical Stimulation
                    6.2.5.1 Ges is Mainly Used for the Treatment of Gerd and Gastroparesis
    6.3 External Neuromodulation
           6.3.1 Transcutaneous Electrical Nerve Stimulation
                    6.3.1.1 Extensive Use in Healthcare, Low Cost, and Ease of Use Will Favor Market Growth
           6.3.2 Transcranial Magnetic Stimulation
                    6.3.2.1 Minimal Patient Discomfort Associated With Tms has Supported the Demand for the Technology
           6.3.3 Respiratory Electrical Stimulation
                    6.3.3.1 Increasing Incidence of Spinal Cord Injuries and High Treatment Efficacy Have Driven Market Growth

7 Neuromodulation Market, By Application (Page No. - 66)
    7.1 Introduction
    7.2 Spinal Cord Stimulation, By Application
           7.2.1 Chronic Pain
                    7.2.1.1 High Incidence of Chronic Pain Supports Market Growth
           7.2.2 Failed Back Surgery Syndrome
                    7.2.2.1 Rising Incidence of Fbss has Driven Demand for Stimulation Technologies
           7.2.3 Ischemia
                    7.2.3.1 High Incidence of Ischemia and Effectiveness of Neuromodulation Supports the Growth of the Market
    7.3 Deep Brain Stimulation, By Application
           7.3.1 Parkinson’s Disease
                    7.3.1.1 Rising Incidence of Parkinson’s Disease and Growing R&D Activity in This Area are Likely to Drive Market Growth
           7.3.2 Tremors
                    7.3.2.1 High Efficacy of Dbs in Treating Tremors has Boosted Demand for the Technology
           7.3.3 Depression
                    7.3.3.1 Use of Dbs in Depression Treatment is Restrained By A Lack of Evidence for Its Efficacy
           7.3.4 Other Dbs Applications
    7.4 Sacral Nerve Stimulation Market, By Application
           7.4.1 Urinary Incontinence
                    7.4.1.1 High Incidence of Urinary Incontinence Offers Growth Opportunities
           7.4.2 Fecal Incontinence
                    7.4.2.1 High Reductions in Symptom Recurrence Have Supported the Use of Sns in Fecal Incontinence Treatment
    7.5 Vagus Nerve Stimulation, By Application
           7.5.1 Epilepsy
                    7.5.1.1 Advantages Associated With Vns in the Treatment of Epilepsy are Expected to Drive the Market
           7.5.2 Other Vns Applications
    7.6 Gastric Electrical Stimulation, By Application
           7.6.1 Gastroparesis
                    7.6.1.1 Ges Treatment Reduces Hospital Stay Duration for Patients Affected By Gastroparesis
           7.6.2 Obesity
                    7.6.2.1 High Prevalence of Obesity and Benefits of Ges are Likely to Drive the Market
    7.7 Transcutaneous Electrical Nerve Stimulation, By Application
           7.7.1 Treatment-Resistant Depression
                    7.7.1.1 High Prevalence of Depression is Driving Market Growth
           7.7.2 Other Tens Applications
    7.8 Transcranial Magnetic Stimulation, By Application
           7.8.1 Depression
                    7.8.1.1 Effectiveness of This Treatment Method and Its Increased Acceptance Among Patients are Driving Demand
           7.8.2 Migraine
                    7.8.2.1 High Prevalence of Migraine is Expected to Increase the Demand for Transcranial Magnetic Stimulation
    7.9 Respiratory Electrical Stimulation, By Application
           7.9.1 Spinal Cord Injury
                    7.9.1.1 High Prevalence of Spinal Cord Injury is Likely to Drive Market Growth in the Future

8 Neuromodulation Market, By Region (Page No. - 81)
    8.1 Introduction
    8.2 North America
           8.2.1 US
                    8.2.1.1 Rising Prevalence of Chronic Diseases is Expected to Increase the Demand for Neuromodulation Devices in the US
           8.2.2 Canada
                    8.2.2.1 Rising Healthcare Expenditure and Increasing Disease Prevalence Will Drive Demand for Neurostimulation
    8.3 Europe
           8.3.1 Germany
                    8.3.1.1 High Healthcare Expenditure and Favorable Government Initiatives Have Ensured Strong Market Growth in Germany
           8.3.2 UK
                    8.3.2.1 High Investment By Public and Private Sectors Play an Important Role in the Growth of the Neuromodulation Market in the UK
           8.3.3 France
                    8.3.3.1 Availability of Insurance and Favorable Healthcare Reforms Have Contributed to the Growth of the French Market
           8.3.4 Italy
                    8.3.4.1 Easy Access to Healthcare Services has Supported the Use of Neuromodulation in Italy
           8.3.5 Spain
                    8.3.5.1 The Growth of This Market Can Be Attributed to the Increasing Incidences of Chronic Diseases
           8.3.6 Rest of Europe
    8.4 Asia Pacific
           8.4.1 Japan
                    8.4.1.1 Japan Dominates the APAC Market for Neuromodulation
           8.4.2 China
                    8.4.2.1 Infrastructural Development, Aging Population, and Rising Disease Incidence Will Favor Market Growth in China
           8.4.3 India
                    8.4.3.1 Improvements in Healthcare Infrastructure in the Country Will Support the Growth of the Neuromodulation Market
           8.4.4 Rest of Asia Pacific
    8.5 Rest of the World
           8.5.1 Latin America
                    8.5.1.1 Latin America Holds the Largest Share of the Neuromodulation Market in the Row
           8.5.2 Middle East & Africa
                    8.5.2.1 The High Cost of Neuromodulation Will Hamper Market Growth in the Region

9 Competitive Landscape (Page No. - 117)
    9.1 Overview
    9.2 Market Share Analysis, 2019
    9.3 Competitive Scenario
    9.4 Competitive Leadership Mapping (Overall Market) (2019)
           9.4.1 Visionary Leaders
           9.4.2 Innovators
           9.4.3 Dynamic Differentiators
           9.4.4 Emerging Companies

10 Company Profiles (Page No. - 123)
(Business Overview, Products Offered, Recent Developments, MnM View)* 
     10.1 Medtronic
     10.2 Boston Scientific Corporation
     10.3 Abbott
     10.4 Livanova
     10.5 Nevro Corporation
     10.6 Neurosigma, Inc.
     10.7 Neuropace, Inc.
     10.8 Biocontrol Medical
     10.9 Synapse Biomedical
     10.10 Neuronetics
     10.11 Bioness
     10.12 Soterix Medical
     10.13 Integer Holdings Corporation
     10.14 Bioinduction
     10.15 Other Players
             10.15.1 Gimer Medical
             10.15.2 GTX Medical
             10.15.3 Helius Medical Technologies
             10.15.4 Microtransponder
             10.15.5 Neuronano
             10.15.6 Bluewind Medical
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. 

11 Appendix (Page No. - 148)
     11.1 Discussion Guide
     11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     11.3 Available Customizations
     11.4 Related Reports
     11.5 Author Details


List of Tables (177 Tables)

Table 1 Indicative List: Neuromodulation Clinical Trials
Table 2 Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 3 Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 4 Internal Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 5 North America: Internal Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 6 Europe: Internal Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 7 APAC: Internal Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 8 RoW: Internal Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 9 Spinal Cord Stimulation Market, By Region, 2018–2025 (USD Million)
Table 10 Spinal Cord Stimulation Market, By Region, 2018–2025 (Units)
Table 11 North America: Spinal Cord Stimulation Market, By Country, 2018–2025 (USD Million)
Table 12 Europe: Spinal Cord Stimulation Market, By Country, 2018–2025 (USD Million)
Table 13 APAC: Spinal Cord Stimulation Market, By Country, 2018–2025 (USD Million)
Table 14 RoW: Spinal Cord Stimulation Market, By Region, 2018–2025 (USD Million)
Table 15 Deep Brain Stimulation Market, By Region, 2018–2025 (USD Million)
Table 16 Deep Brain Stimulation Market, By Region, 2018–2025 (Units)
Table 17 North America: Deep Brain Stimulation Market, By Country, 2018–2025 (USD Million)
Table 18 Europe: Deep Brain Stimulation Market, By Country, 2018–2025 (USD Million)
Table 19 APAC: Deep Brain Stimulation Market, By Country, 2018–2025 (USD Million)
Table 20 RoW: Deep Brain Stimulation Market, By Region, 2018–2025 (USD Million)
Table 21 Vagus Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 22 Vagus Nerve Stimulation Market, By Region, 2018–2025 (Units)
Table 23 North America: Vagus Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 24 Europe: Vagus Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 25 APAC: Vagus Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 26 RoW: Vagus Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 27 Sacral Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 28 Sacral Nerve Stimulation Market, By Region, 2018–2025 (Units)
Table 29 North America: Sacral Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 30 Europe: Sacral Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 31 APAC: Sacral Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 32 RoW: Sacral Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 33 Gastric Electrical Stimulation Market, By Region, 2018–2025 (USD Million)
Table 34 Gastric Electrical Stimulation Market, By Region, 2018–2025 (Units)
Table 35 North America: Gastric Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 36 Europe: Gastric Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 37 APAC: Gastric Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 38 RoW: Gastric Electrical Stimulation Market, By Region, 2018–2025 (USD Million)
Table 39 External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 40 External Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 41 North America: External Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 42 Europe: External Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 43 APAC: External Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 44 RoW: External Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 45 Transcutaneous Electrical Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 46 Transcutaneous Electrical Nerve Stimulation Market, By Region, 2018–2025 (Units)
Table 47 North America: Transcutaneous Electrical Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 48 Europe: Transcutaneous Electrical Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 49 APAC: Transcutaneous Electrical Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 50 RoW: Transcutaneous Electrical Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 51 Transcranial Magnetic Stimulation Market, By Region, 2018–2025 (USD Million)
Table 52 Transcranial Magnetic Stimulation Market, By Region, 2018–2025 (Units)
Table 53 North America: Transcranial Magnetic Stimulation Market, By Country, 2018–2025 (USD Million)
Table 54 Europe: Transcranial Magnetic Stimulation Market, By Country, 2018–2025 (USD Million)
Table 55 APAC: Transcranial Magnetic Stimulation Market, By Country, 2018–2025 (USD Million)
Table 56 RoW: Transcranial Magnetic Stimulation Market, By Region, 2018–2025 (USD Million)
Table 57 Respiratory Electrical Stimulation Market, By Region, 2018–2025 (USD Million)
Table 58 Respiratory Electrical Stimulation Market, By Region, 2018–2025 (Units)
Table 59 North America: Respiratory Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 60 Europe: Respiratory Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 61 APAC: Respiratory Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 62 RoW: Respiratory Electrical Stimulation Market, By Region, 2018–2025 (USD Million)
Table 63 Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 64 Spinal Cord Stimulation Market for Chronic Pain, By Region, 2018–2025 (USD Million)
Table 65 Spinal Cord Stimulation Market for Failed Back Surgery Syndrome,By Region, 2018–2025 (USD Million)
Table 66 Spinal Cord Stimulation Market for Ischemia, By Region, 2018–2025 (USD Million)
Table 67 Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 68 Deep Brain Stimulation Market for Parkinson’s Disease, By Region, 2018–2025 (USD Million)
Table 69 Deep Brain Stimulation Market for Tremors, By Region, 2018–2025 (USD Million)
Table 70 Deep Brain Stimulation Market for Depression, By Region, 2018–2025 (USD Million)
Table 71 Deep Brain Stimulation Market for Other Applications, By Region, 2018–2025 (USD Million)
Table 72 Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 73 Sacral Nerve Stimulation Market for Urinary Incontinence, By Region, 2018–2025 (USD Million)
Table 74 Sacral Nerve Stimulation Market for Fecal Incontinence, By Region, 2018–2025 (USD Million)
Table 75 Vagus Nerve Market, By Application, 2018–2025 (USD Million)
Table 76 Vagus Nerve Stimulation Market for Epilepsy, By Region, 2018–2025 (USD Million)
Table 77 Vagus Nerve Stimulation Market for Other Applications, By Region, 2018–2025 (USD Million)
Table 78 Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 79 Gastric Electrical Stimulation Market for Gastroparesis, By Region, 2018–2025 (USD Million)
Table 80 Gastric Electrical Stimulation Market for Obesity, By Region, 2018–2025 (USD Million)
Table 81 Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 82 Transcutaneous Electrical Nerve Stimulation Market for Treatment-Resistant Depression, By Region, 2018–2025 (USD Million)
Table 83 Transcutaneous Electrical Nerve Stimulation Market for Other Applications, By Region, 2018–2025 (USD Million)
Table 84 Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 85 Transcranial Magnetic Stimulation Market for Depression, By Region, 2018–2025 (USD Million)
Table 86 Transcranial Magnetic Stimulation Market for Migraine, By Region, 2018–2025 (USD Million)
Table 87 Respiratory Electrical Stimulation Market for Spinal Cord Injury, By Region, 2018–2025 (USD Million)
Table 88 Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 89 North America: Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 90 North America: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 91 North America: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 92 North America: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 93 North America: Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 94 North America: Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 95 North America: Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 96 North America: Vagus Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 97 North America: Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 98 North America: Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 99 North America: Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 100 US: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 101 US: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 102 US: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 103 Canada: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 104 Canada: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 105 Canada: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 106 Europe: Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 107 Europe: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 108 Europe: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 109 Europe: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 110 Europe: Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 111 Europe: Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 112 Europe: Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 113 Europe: Vagus Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 114 Europe: Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 115 Europe: Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 116 Europe: Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 117 Germany: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 118 Germany: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 119 Germany: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 120 UK: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 121 UK: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 122 UK: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 123 France: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 124 France: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 125 France: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 126 Italy: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 127 Italy: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 128 Italy: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 129 Spain: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 130 Spain: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 131 Spain: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 132 RoE: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 133 RoE: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 134 RoE: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 135 Asia Pacific: Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 136 Asia Pacific: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 137 Asia Pacific: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 138 Asia Pacific: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 139 Asia Pacific: Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 140 Asia Pacific: Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 141 Asia Pacific: Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 142 Asia Pacific: Vagus Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 143 Asia Pacific: Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 144 Asia Pacific: Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 145 Asia Pacific: Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 146 Japan: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 147 Japan: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 148 Japan: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 149 China: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 150 China: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 151 China: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 152 India: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 153 India: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 154 India: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 155 RoAPAC: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 156 RoAPAC: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 157 RoAPAC: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 158 RoW: Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 159 RoW: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 160 RoW: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 161 RoW: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 162 RoW: Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 163 RoW: Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 164 RoW: Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 165 RoW: Vagus Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 166 RoW: Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 167 RoW: Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 168 RoW: Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 169 Latin America: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 170 Latin America: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 171 Latin America: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 172 MEA: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 173 MEA: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 174 MEA: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 175 Agreements and Partnerships (2017–2020)
Table 176 Acquisitions (2017–2020)
Table 177 Product Launches and Approvals (2017–2020)


List of Figures (25 Figures)

Figure 1 Neuromodulation Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Neuromodulation Market, By Technology, 2020–2025
Figure 8 Internal Neuromodulation Market, By Type, 2020–2025
Figure 9 External Neuromodulation Market, By Type, 2020–2025
Figure 10 Neuromodulation Market: Geographic Snapshot
Figure 11 Rising Prevalence of Neurological Disorders Will Drive the Growth of the Neuromodulation Market
Figure 12 Internal Neuromodulation Accounted for the Largest Share of the North American Market in 2019
Figure 13 Chronic Pain Accounts for the Largest Share of the Market During the Forecast Period
Figure 14 Neuromodulation Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 North America: Neuromodulation Market Snapshot
Figure 16 Asia Pacific: Neuromodulation Market Snapshot
Figure 17 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2017 and 2020
Figure 18 Market Ranking of Key Players, 2019
Figure 19 Competitive Leadership Mapping: Neuromodulation Market
Figure 20 Medtronic: Company Snapshot
Figure 21 Boston Scientific Corporation: Company Snapshot
Figure 22 Abbott: Company Snapshot
Figure 23 Livanova: Company Snapshot
Figure 24 Nevro Corporation: Company Snapshot
Figure 25 Integer Holdings Corporation: Company Snapshot

The neuromodulation market study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for this extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the market. Primary sources from the demand side included industry experts, such as researchers & scientists. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Neurostimulation Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The neuromodulation market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by technology, application, and region).

Data Triangulation

After arriving at the market size, the market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.

Objectives of the Study

  • To define, describe, segment, and forecast the global neuromodulation market by technology, application, and region
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market in five main regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
  • To profile key players in the global market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as product/service launches, partnerships, and collaborations in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 3)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Neuromodulation Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Neuromodulation Market

Request For Special Pricing
Report Code
BT 3571
Published ON
Feb, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Neuromodulation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home